Stephen L Chan Selected Research

Stephen L Chan Research Topics

Disease

74	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2009
47	Neoplasms (Cancer) 02/2024 - 07/2007
8	Liver Neoplasms (Liver Cancer) 12/2023 - 02/2011
7	Nasopharyngeal Carcinoma 07/2023 - 10/2006
6	Hypertension (High Blood Pressure) 02/2024 - 12/2016
6	Hepatitis B 10/2016 - 06/2007
4	Vomiting 04/2024 - 03/2014
4	Nausea 04/2024 - 03/2014
4	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 07/2023 - 03/2012
4	Disease Progression 06/2023 - 01/2016
4	Liver Diseases (Liver Disease) 03/2022 - 09/2012
4	Infections 01/2016 - 06/2007
3	Multiple Organ Failure (MODS) 02/2024 - 01/2022
3	Neoplasm Metastasis (Metastasis) 01/2020 - 10/2006
3	Diarrhea 12/2019 - 01/2016
3	Inflammation (Inflammations) 09/2019 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 12/2013
3	Fatigue 07/2018 - 01/2016
2	Exanthema (Rash) 04/2024 - 01/2016
2	Fever (Fevers) 04/2024 - 01/2016
2	Asthenia 04/2024 - 02/2024
2	Microsatellite Instability 02/2024 - 03/2015
2	Varicose Veins (Varicose Vein) 02/2024 - 01/2022
2	Hepatic Encephalopathy 02/2024 - 01/2022
2	Chemical and Drug Induced Liver Injury 02/2024 - 01/2022
2	Tumor Lysis Syndrome 02/2024 - 01/2022
2	Adenocarcinoma 01/2020 - 05/2013
1	Cholangiocarcinoma 04/2024
1	Pruritus (Itching) 04/2024
1	Melanoma (Melanoma, Malignant) 02/2024
1	Sepsis (Septicemia) 02/2024
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Shock 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Alcoholic Fatty Liver 03/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Enterocolitis 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Hemorrhage 12/2020

Drug/Important Bio-Agent (IBA)

20	Sorafenib (BAY 43-9006)FDA Link 02/2024 - 05/2012
14	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 10/2006
12	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2007
11	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2018
10	AlbuminsIBA 04/2021 - 01/2015
8	pembrolizumabIBA 09/2023 - 01/2018
8	BilirubinIBA 04/2021 - 06/2007
8	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2020 - 01/2009
6	cabozantinibIBA 03/2024 - 07/2018
5	atezolizumabIBA 04/2024 - 01/2022
5	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2024 - 01/2018
4	Alanine Transaminase (SGPT)IBA 02/2024 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2007
3	Bevacizumab (Avastin)FDA Link 04/2024 - 03/2022
3	Phosphotransferases (Kinase)IBA 10/2023 - 11/2014
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 09/2012
3	Cell-Free Nucleic AcidsIBA 01/2022 - 03/2015
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2018 - 01/2016
2	spartalizumabIBA 04/2024 - 06/2022
2	Apoptosis Regulatory ProteinsIBA 02/2024 - 06/2022
2	tremelimumabIBA 12/2023 - 08/2022
2	durvalumabIBA 12/2023 - 08/2022
2	lenvatinibIBA 10/2023 - 01/2023
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 03/2014
2	C-Reactive ProteinIBA 09/2019 - 01/2019
2	Histone MethyltransferasesIBA 01/2019 - 05/2013
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2016 - 02/2012
2	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 01/2016 - 06/2013
2	Everolimus FDA Link 05/2015 - 06/2013
2	Fetal Proteins (Fetoprotein)IBA 03/2015 - 04/2014
2	belinostatIBA 09/2012 - 04/2010
2	Histone Deacetylase InhibitorsIBA 09/2012 - 04/2010
1	capmatinibIBA 04/2024
1	CS-1003IBA 02/2024
1	Monoclonal AntibodiesIBA 02/2024
1	apatinibIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	camrelizumabIBA 01/2023
1	Nucleic AcidsIBA 07/2022
1	roblitinibIBA 06/2022
1	NivolumabIBA 03/2022
1	Circulating Tumor DNAIBA 01/2022
1	SirtuinsIBA 01/2022
1	ChromatinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Arginine (L-Arginine)FDA Link 10/2021
1	ArginaseIBA 10/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	CyanoacrylatesIBA 12/2020

Therapy/Procedure

25	Therapeutics 04/2024 - 02/2009
9	Drug Therapy (Chemotherapy) 01/2023 - 10/2006
5	Radiotherapy 01/2024 - 04/2011
4	Immunotherapy 01/2024 - 01/2020
3	Hepatectomy 05/2020 - 02/2017
3	Surgical Instruments (Clip) 01/2017 - 02/2011
2	Chemoradiotherapy 01/2023 - 09/2012
2	Liver Transplantation 01/2023 - 10/2015
2	Organ Transplantation 11/2022 - 01/2019
2	Transplantation 01/2021 - 10/2015
2	Aftercare (After-Treatment) 01/2019 - 01/2018